Protonix Delayed-Release NDC 0008-0841

NDC codes

FDA NDC Directory

Product NDC (as listed)0008-0841Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00008-0841Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0008-0841-81	00008084181	90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0841-81)Marketed from May 1, 2000

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Protonix Delayed-ReleaseSuffix: Delayed-Release
Generic name (nonproprietary): pantoprazole sodium
Active ingredients: Pantoprazole sodium — 40 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020987
Marketing start: May 1, 2000
Listing expires: Dec 31, 2027
Other FDA classes: Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 0008-0841_b1adaee5-9353-48ce-bde4-f169a3787e30SPL ID b1adaee5-9353-48ce-bde4-f169a3787e30SPL set ID 08098cb2-c048-4640-f387-6beec4a38936RxCUI 251872, 284400, 314200, 352125, 763306, 763308UNII 6871619Q5XUPC 0300080843819, 0300080841815
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400008084181 followed by a unit qualifier and the quantity

Package 00008-0841-81. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 18, 2026.

Indications (excerpt from the label)

PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets are indicated for: PROTONIX is a proton pump inhibitor (PPI) indicated for the following: • Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) ( 1.1 ) • Maintenance of Healing of Erosive Esophagitis ( 1.2 ) • Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome ( 1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) PROTONIX is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020987

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020987
Product	Strength	Form · route	Labeler	Product NDC
Protonix Delayed-Releasepantoprazole sodium	Pantoprazole sodium 20 mg/1	Tablet, Delayed releaseOral	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	0008-0843

Protonix Delayed-Release (pantoprazole sodium) NDC 0008-0841